• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Healthcare

Align Technology Has Broken Its Bullish Alignment

Should investors still sink their teeth into this one?
By BRUCE KAMICH
Sep 12, 2023 | 02:25 PM EDT
Stocks quotes in this article: ALGN

I last reviewed the charts of Align Technology (ALGN) on July 17, writing that "Traders could go long ALGN or add to longs on ALGN on weakness near the $360 area. Risk to $330. The $425 area is my nearest price target."

ALGN has broken below $330 so traders should be stopped out of longs now.

Let's check the charts again to see if this is the start of further declines in the weeks ahead.

In the daily bar chart of ALGN, below, I can see that the shares have turned down below the 50-day moving average line and the slower-to-react 200-day moving average line is not all that far below the price action now.

The On-Balance-Volume (OBV) line has been weak since February and that tells me that sellers of ALGN have been more aggressive than buyers for several months now. The Moving Average Convergence Divergence (MACD) oscillator is now crossing below the zero line for an outright sell signal.

 
In the weekly Japanese candlestick chart of ALGN, below, I can see a less-than-stellar picture. Prices are weakening and are only a few dollars above the rising 40-week moving average line.
 
The weekly OBV line has been stalled the past four months. The MACD oscillator is above the zero line but weakening.
 
 
In this daily Point and Figure chart of ALGN, below, I can see a tentative downside price target in the $280 area.
 
 
In this second Point and Figure chart of ALGN, below, I used weekly price data with a five-box reversal filter. Here the software suggests a downside price objective in the $220 area.
 
 
Bottom-line strategy: The charts are lining up for further declines in the weeks and months ahead.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Technical Analysis | Trading | Health Care Equipment & Services | Healthcare | U.S. Equity

More from Healthcare

An Update on My Top Small-Cap Pick and What It Means for the Overall Market

James "Rev Shark" DePorre
Sep 26, 2023 11:30 AM EDT

The good news is that the corrective action is advancing and opportunities are developing.

Moderna's Chart Messages Are Frustrating the Bulls

Bruce Kamich
Sep 19, 2023 9:20 AM EDT

The technical indicators suggest that traders should wait until a bottom pattern plays out in the shares of the vaccine maker.

This Biotech Stock Pick Is Just Starting to Make Beautiful Music

Bret Jensen
Sep 15, 2023 9:00 AM EDT

Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.

UnitedHealth Shares Are Not Looking All That Healthy

Bruce Kamich
Sep 14, 2023 11:05 AM EDT

Let's take the temperature of this important Dow component.

Moderna: Is It Time to Take a Shot?

Bruce Kamich
Sep 13, 2023 12:52 PM EDT

Let's review the trends, charts and indicators.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:21 PM EDT BRUCE KAMICH

    19 Trading Rules From 'Trader Vic'

    I heard Victor Sperandeo (aka "Trader Vic") speak ...
  • 07:54 AM EDT BRUCE KAMICH

    Martin Zweig's Investment Rules

    The late Marty Zweig was a professor, money manage...
  • 09:43 AM EDT BRUCE KAMICH

    Bob Farrell's 10 Rules of Investing

    I always take a hard copy book to read when I trav...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login